Publications by authors named "Joan Balayan"

Claim this Profile
P
Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER.
Jeff Hsu, Colin Chong, Jeffrey Serrill, Levina Goon, Joan Balayan

Mol Cancer Therยท February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis